When The Pandemic Came, Zoos Closed, And The Animals Started to Act Differently
We all had to make adjustments as the COVID-19 pandemic unfolded – even zoo animals who were suddenly not seeing crowds of visitors pass by every single day.
In a study published in 2022, researchers discovered how primates reacted to that shift, looking at the behavior of bonobos, chimpanzees, western lowland gorillas, and olive baboons, and finding that the animals changed their habits in a variety of ways, including the amount of time they spent resting and eating.
Visitor interactions are thought to be crucial to the welfare of zoo animals. Yet these interactions have the potential to be either positive or negative. So the researchers were keen to see the difference when the crowds weren't there.
"Primates are some of the most cognitively advanced species in zoos and their interactions with visitors are complex," zoo animal welfare scientist Samantha Ward from Nottingham Trent University in the UK explained at the time.
"A limitation to understanding how visitors can affect behavior of animals in zoos and parks is that they rarely close to the public for prolonged periods, so this provided us with a unique opportunity."
Observations were recorded at Twycross Zoo and Knowsley Safari in the UK, both before and after visitors returned.
Over several months and multiple open and closure periods, there were noticeable changes in primate behavior, which varied depending on the animal.
As visitors began to return to the zoo, the bonobos and gorillas spent less time alone, while the gorillas also spent less time resting. Chimpanzees, meanwhile, were eating more and engaging with their enclosures more when zoos reopened.
The olive baboons in the safari park were seen to engage in less sexual and dominance behavior when the visitors came back. They also tended to approach visitor cars more often, compared with the ranger vehicles they saw when the park was closed.
Whether or not these changes were positive is more difficult to say.
The researchers suggest that the returning visitors seemed to stimulate the chimpanzees and baboons, while gorillas and bonobos spending less time alone could also be viewed as positive.
At the same time, it could be argued that gorillas – naturally more sedentary animals – were disrupted by the crowds in that they spent less time resting.
That the gorillas changed the parts of their enclosures they spent the most time in when visitors came back suggests that the animals can to some extent manage this disruption.
"Behavioral changes and changes in enclosure use in the presence of visitors highlights the adaptability of zoo species to their environments," said zoo animal welfare researcher Ellen Williams from Harper Adams University in the UK.
"Provision of environments which enable animals to actively adapt in this manner is really important for their welfare."
The team also observed that there was a visitor number threshold when it came to olive baboons, beyond which the animals stopped becoming increasingly active and stimulated by the passing cars in the safari park.
This is all valuable data for animal welfare researchers, who know that visitors can have all kinds of effects on wildlife – from adding feelings of companionship and safety, to being sources of annoyance or even threats. This needs to be factored into how zoos and parks are run and designed.
While there might not be any more lockdowns in the foreseeable future (hopefully), the research team wants to continue the work of studying how visitor numbers affect animal behavior, including collecting data involving more animals and across a longer time scale.
"Future work could involve looking at the impact on a wider range of species in both zoos and safari parks as well as differences among individual animals," said Williams.
The research was published in Animals.
An earlier version of this article was published in September 2022.
Largest Single Flood May Have Filled Mediterranean 5 Million Years Ago
Life Deep Beneath The Soil Dominated by Mysterious New Phylum of Bacteria
This Fungus Contains The Most Bitter Substance Known to Humankind

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
10 hours ago
- Yahoo
Final decision due on Porton Down science labs
A decision is finally expected on whether to move hundreds of government science jobs out of Wiltshire to Essex. The Health Security Agency at Porton Down researches how to tackle the world's most infectious diseases, and prepare the UK for future pandemics. Over the last 15 years plans have been worked up to relocate its 900 workers to new facilities in Harlow, but the estimated costs have spiralled - ministers expect a final decision in Wednesday's government spending review. The MP covering Porton Down - Conservative John Glen - said: "It's taken 10 years to still be in doubt whether this should still happen and the costs have gone up six-fold." The National Audit Office reported the cost of the whole project is estimated to be £3.2bn, a figure more than 500% higher than the initial forecast of £530m. When it was officially announced in 2015 that the labs would move to Harlow, Essex, the MP there at the time said he was pleased and it would "bring thousands of jobs". Speaking to the BBC this week, Mr Glen said the new build would be "dressed up" as a world-class hub. "But Porton Down already is world-class," he said. "We've already got the world's best scientists doing amazing collaborative work." More news stories for Wiltshire Listen to the latest news for Wiltshire He added staff get paid to do work for other countries, including the US, and when unions asked workers there several years ago, most did not want to move. He said: "There's an established pattern of activity there. We do need more investment but not the extent of building and refurbishing an unsuitable lab in Harlow." Scientific work has been going on at Porton Down for 100 years, but much the infrastructure is old. However, Mr Glen said there had been "additional investment" because of the Covid-19 pandemic, so the government needs to "be realistic". "This is an opportunity to save money, to reverse George Osborne's ambitious decision but still invest in science and an established rhythm of work," he said. No construction work has started at the Harlow site, which is being maintained by staff to keep it secure. The government said it had been considering options and whether building a new facility is still viable. It estimates if the Harlow centre is built, it will not open before 2036 - some 15 years behind schedule. When Health Secretary Wes Streeting was asked about the possible move in March, he said: "[This] has been running around the system so long that it is now used in a case study for senior civil servant recruitment," he said. "The worst decision is indecision. "It has plagued us for too long and I hope we can soon report back to the house with a decision on that for everyone's benefit." Follow BBC Wiltshire on Facebook, X and Instagram. Send your story ideas to us on email or via WhatsApp on 0800 313 4630. Deadly pathogen research hub remains unbuilt despite £400m spend Work paused on dangerous pathogens research facility Site purchase promises thousands of jobs Public Health lab move confirmed Can this laboratory help stop the next pandemic?


Boston Globe
11 hours ago
- Boston Globe
FDA looks to AI to enhance efficiency
Get Starting Point A guide through the most important stories of the morning, delivered Monday through Friday. Enter Email Sign Up The agency plays a central role in pursuing the agenda of the US health secretary, Robert F. Kennedy Jr., and it has already begun to press food makers to eliminate artificial food dyes. The new road map also underscores the Trump administration's efforts to smooth the way for major industries with an array of efforts aimed at getting products to pharmacies and store shelves quickly. Advertisement Some aspects of the proposals outlined in JAMA were met with skepticism, particularly the idea that AI is up to the task of shearing months or years from the painstaking work of examining applications that companies submit when seeking approval for a drug or high-risk medical device. Advertisement 'I don't want to be dismissive of speeding reviews at the FDA,' said Stephen Holland, a lawyer who formerly advised the House Committee on Energy and Commerce on health care. 'I think that there is great potential here, but I'm not seeing the beef yet.' A major AI rollout closely follows the release of a report by Kennedy's MAHA Commission, which uses an acronym for Make America Healthy Again, that was found to be rife with references to scientific research apparently fabricated by an AI program. For some cases, the FDA officials proposed speeding major drug approvals by requiring only one major study in patients rather than two, a practice the agency has used in recent years. The pandemic provided a precedent, they said, for accelerating the process. 'We believe this is clear demonstration that rapid or instant reviews are possible,' Makary and Prasad wrote. But Holland pointed out that during the pandemic, many staff members were transferred from routine duties, including overseas inspections of food or drug facilities, and reassigned to hasten critical COVID product reviews. The agency was also better staffed. In recent months, the FDA shed about 1,940 employees, reducing the workforce to 8,000 from roughly 10,000. Last week, the agency introduced Elsa, an AI large-language model similar to ChatGPT. The FDA said it could be used to prioritize which food or drug facilities to inspect, to describe side effects in drug safety summaries and to perform other basic product-review tasks. The FDA officials wrote that AI held the promise to 'radically increase efficiency' in examining as many as 500,000 pages submitted for approval decisions. Advertisement Current and former health officials said the AI tool was helpful but far from transformative. For one, the model limits the number of characters that can be reviewed, meaning it is unable to do some rote data analysis tasks. Its results must be checked carefully, so far saving little time. Staff members said the model was hallucinating, or producing false information. Employees can ask the Elsa model to summarize text or act as an expert in a particular field of medicine. Makary said the AI models were not being trained by data submitted by the drug or medical device industry. When it comes to food oversight, Makary and Prasad said there would be a renewed focus on 'our increasingly chemically manipulated diet,' a goal embraced by Republicans and Democrats. 'For all additives,' the article said, 'the benefit-to-harm balance must be reevaluated.' Although the Trump administration is seeking steep cuts in the FDA's budget for the next fiscal year, the food division is expected to receive additional funds. Others noted the fine line agency officials were walking, given Kennedy's complaints that the FDA is too close to the drug industry and the Trump administration's business-friendly approach. Makary and Prasad wrote that the FDA must be 'partners with industry' while avoiding 'a cozy relationship that has characterized the agency in the past.' Dr. Reshma Ramachandran, a director of the Yale Collaboration for Regulatory Rigor, Integrity and Transparency, pointed out that Makary and Prasad were going on a six-city, closed-door listening tour to meet with chief executives of the drug industry. 'How is this guarding the agency 'against a cozy relationship' with industry?' she asked. The FDA priorities 'read as though they're straight out of PhRMA's playbook,' she said, referring to the trade group. Advertisement This article originally appeared in
Yahoo
11 hours ago
- Yahoo
When Letting Your Mind Wander Helps You Learn
While you do the dishes or drive to work, your mind is likely not on the task at hand; perhaps you're composing a grocery list or daydreaming about retiring in Italy. But research published in the Journal of Neuroscience suggests you might be taking in more than you think. During a simple task that requires minimal attention, mind wandering may actually help people learn probabilistic patterns that let them perform the task better. 'The idea to study the potentially beneficial influence of mind wandering on information processing occurred to us during the COVID pandemic, when we had plenty of time to mind wander,' says Péter Simor, lead author of the recent study and a psychology researcher at Eötvös Loránd University in Budapest. Study participants practiced a simple task in which they pressed keyboard buttons corresponding to the direction of arrows that lit up on a screen. But there were patterns hidden within the task that the participants were unaware of—and they learned these patterns without consciously noticing them. The researchers found that when participants reported letting their minds wander, they adapted to the task's hidden patterns significantly faster. [Sign up for Today in Science, a free daily newsletter] 'This is an exciting and important piece of work, especially because the authors opted for a nondemanding task to check how [mind wandering] would affect performance and learning,' says Athena Demertzi, a cognitive and clinical neuroscientist at the University of Liège in Belgium. Previous related research focused more on long and demanding tasks, she says—on which zoning out is typically shown to have a negative effect. But the results are not clear-cut, says Jonathan Smallwood, a psychology researcher at Queen's University in Kingston, Ontario. 'I don't think that this means the spontaneous mind-wandering episodes themselves cause implicit learning to occur,' he says. 'Rather both emerge at the same time when people go into a particular state.' Neither Smallwood nor Demertzi was involved in the new study. Simor, who studies sleep, was interested in whether participants' mind wandering displayed any neural hallmarks of dozing off. Using electroencephalogram recordings, the team showed that in those test periods, participants' brains produced more of the slow waves that are dominant during sleep. Perhaps, the researchers say, mind wandering is like a form of light sleep that provides some of that state's learning benefits. To better understand whether mind wandering might compensate for lost sleep, Simor and his colleagues next plan to study narcolepsy and sleep deprivation. 'We know that people spend significant amounts of time not focused on what they are doing,' Smallwood says. 'The authors' work is important because it helps us understand how reasonably complex forms of behavior can continue when people are focused on other things—and that even though our thoughts were elsewhere, the external behavior can still leave its mark on the person.'